China-America Technology Corp (CTC), based in New York City, USA, has announced a formal agreement with the Chinese Academy of Sciences in Beijing, as well as other key Chinese research institutions, to provide US business communities with access to "breakthrough products and technologies" developed by top Chinese scientists.
Under the terms of the agreement, US companies will be able to subscribe to a bimonthly ChinaTech Listing Service, which will highlight 20 to 30 new technologies and products per issue developed by leading Chinese scientists. Wide-ranging technology to be covered is expected to include medical and pharmaceutical disciplines, as well as laser technology, synchrotron radiation, photonics, consumer products, telecommunications, manufacturing and testing/measurement.
Individual research profiles in ChinaTech Listing Service will include product features, development background, and specific marketing opportunities. Subscribers to ChinaTech Listing Service will have the "exclusive right" to receive in-depth research data and to negotiate for "outright purchase" leasing rights, North American distributorship or joint development rights.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze